There were no cases of level 2 or level 3 hypoglycemic episodes reported
If you have looked into our Repair & Glow protocol (BPC-157 + TB-500 + GHK-Cu), KLOW is the expanded version
Crucially, BPC 157 might act as the particular peptidergic agent that implements the cytoprotective capabilities, and pleiotropic beneficial effects [1,3,4,5,6,9,32,33,34,92] (as noted above, largely involving the muscle healing and function recovery of striated, smooth and heart muscle) [1,3,4,5,6,9,32,33,34,92]
By targeting the stubborn, pro-inflammatory senescent cells that accumulate with age, FOXO4-DRI offers the possibility of clearing the cellular garbage that impedes regeneration, contributes to chronic disease and ageing decline